Celsee's Genesis system helps scientists isolate, interpret, and analyze the behavior of single cells. The technology is designed for single-cell cytometry, single-cell transcriptomics, single-cell multiomics, rare-cell enrichment and enumeration, and immune monitoring.

Bio-Rad did not disclose terms of the acquisition, but it will provide further updates regarding Celsee during its first-quarter 2020 financial results call.